Madhu Mazumdar

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint A statistical simulation study finds discordance between WHO criteria and RECIST guideline
    Madhu Mazumdar
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd St, 3rd Floor, New York, NY 10021, USA
    J Clin Epidemiol 57:358-65. 2004
  2. doi request reprint Total number of resected lymph nodes predicts survival in esophageal cancer
    Nasser K Altorki
    Division of Thoracic Surgery, New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York 10021, USA
    Ann Surg 248:221-6. 2008
  3. ncbi request reprint Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point
    Jose G Guillem
    Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
    J Clin Oncol 23:3475-9. 2005
  4. doi request reprint FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation
    Jeannine A Ruby
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Dis Colon Rectum 55:378-86. 2012
  5. ncbi request reprint Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer
    Jose G Guillem
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 199:1-7. 2004
  6. ncbi request reprint Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study
    Ottokar Stundner
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Clin Exp Rheumatol 31:889-95. 2013
  7. pmc Perioperative comparative effectiveness of anesthetic technique in orthopedic patients
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Anesthesiology 118:1046-58. 2013
  8. ncbi request reprint Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome
    Harvey G Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 1077, New York, NY 10021, USA
    Ann Surg Oncol 11:955-61. 2004
  9. pmc The impact of sleep apnea on postoperative utilization of resources and adverse outcomes
    Stavros G Memtsoudis
    From the Department of Anesthesiology, Hospital for Special Surgery, Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, New York Department of Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio and Department of Anesthesiology, NewYork Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York
    Anesth Analg 118:407-18. 2014
  10. doi request reprint Demographics and perioperative outcome in patients with depression and anxiety undergoing total joint arthroplasty: a population-based study
    Ottokar Stundner
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Psychosomatics 54:149-57. 2013

Detail Information

Publications100

  1. ncbi request reprint A statistical simulation study finds discordance between WHO criteria and RECIST guideline
    Madhu Mazumdar
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd St, 3rd Floor, New York, NY 10021, USA
    J Clin Epidemiol 57:358-65. 2004
    ..Empirical evidence supporting this fact was provided by retrospective analysis of several large datasets...
  2. doi request reprint Total number of resected lymph nodes predicts survival in esophageal cancer
    Nasser K Altorki
    Division of Thoracic Surgery, New York Presbyterian Hospital and Weill Cornell Medical College, New York, New York 10021, USA
    Ann Surg 248:221-6. 2008
    ..In this retrospective study, the impact of total nodal count on overall survival in esophageal cancer was examined using a single institution surgical database...
  3. ncbi request reprint Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point
    Jose G Guillem
    Colorectal Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Room C 1077, New York, NY 10021, USA
    J Clin Oncol 23:3475-9. 2005
    ..However, because the accuracy of this approach has not been established, we conducted a prospective analysis to determine the operating surgeon's ability to assess response using DRE...
  4. doi request reprint FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation
    Jeannine A Ruby
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Dis Colon Rectum 55:378-86. 2012
    ..At present there is no defined role for routine FDG-PET in the preoperative evaluation of nonmetastatic rectal cancer...
  5. ncbi request reprint Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer
    Jose G Guillem
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 199:1-7. 2004
    ..Our goal was to determine the prognostic significance of FDG-PET assessment of rectal cancer response to preoperative chemoradiation...
  6. ncbi request reprint Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study
    Ottokar Stundner
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Clin Exp Rheumatol 31:889-95. 2013
    ....
  7. pmc Perioperative comparative effectiveness of anesthetic technique in orthopedic patients
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Anesthesiology 118:1046-58. 2013
    ..We studied a large national sample of primary joint arthroplasty recipients and hypothesized that neuraxial anesthesia favorably influences perioperative outcomes...
  8. ncbi request reprint Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome
    Harvey G Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 1077, New York, NY 10021, USA
    Ann Surg Oncol 11:955-61. 2004
    ..Although numerous studies have focused on identifying molecular markers of prognosis in the primary rectal cancer before CMT, our aim was to identify markers of prognosis in residual rectal cancer after preoperative CMT...
  9. pmc The impact of sleep apnea on postoperative utilization of resources and adverse outcomes
    Stavros G Memtsoudis
    From the Department of Anesthesiology, Hospital for Special Surgery, Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, New York Department of Anesthesiology, University of Michigan Health System, Ann Arbor, Michigan Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio and Department of Anesthesiology, NewYork Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York
    Anesth Analg 118:407-18. 2014
    ..With an increasing number of surgical patients suffering from SA, this information is important to physicians, patients, policymakers, and administrators alike...
  10. doi request reprint Demographics and perioperative outcome in patients with depression and anxiety undergoing total joint arthroplasty: a population-based study
    Ottokar Stundner
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY, USA
    Psychosomatics 54:149-57. 2013
    ..This study is intended to gain insight into epidemiology and effects on perioperative morbidity, mortality, length of hospital stay, discharge and cost...
  11. ncbi request reprint Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Robert J Motzer
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:247-56. 2007
    ..Serum tumor marker decline during chemotherapy was assessed prospectively as a predictor of treatment outcome...
  12. doi request reprint Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment
    Nasser K Altorki
    Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY 10021, USA
    Ann Surg 247:434-9. 2008
    ....
  13. doi request reprint Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis
    Tobias Leibold
    Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:2783-9. 2011
    ..We prospectively evaluated tumor response with (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) early in the course of preoperative CRT...
  14. ncbi request reprint Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy
    G Varuni Kondagunta
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 22:464-7. 2004
    ....
  15. pmc Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer
    Jose G Guillem
    Department of Surgery Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 241:829-36; discussion 836-8. 2005
    ....
  16. doi request reprint Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study
    Jose G Guillem
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 258:289-95. 2013
    ..To prospectively compare the ability of flourodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography (CT) to identify a pathological complete response (pCR) in patients with rectal cancer treated by chemoradiation...
  17. doi request reprint Preoperative patient expectations of total shoulder arthroplasty
    R Frank Henn
    Hospital for Special Surgery, New York, NY, USA
    J Bone Joint Surg Am 93:2110-5. 2011
    ..We hypothesized that younger patients and patients with worse function and worse general health would have greater expectations of total shoulder arthroplasty...
  18. pmc Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients
    Bruce Ng
    Department of Dermatology, New York University School of Medicine, 522 First Avenue, New York, NY 10016, USA
    Clin Cancer Res 14:6253-8. 2008
    ..In this study, we investigated the clinical relevance of HUI77 shedding in melanoma patient sera...
  19. ncbi request reprint Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor
    Madhu Mazumdar
    Memorial Sloan Kettering Cancer Center, 307 E 63rd St, 3rd Floor, New York, NY 10021, USA
    J Clin Oncol 21:2679-88. 2003
    ..We sought to determine whether simultaneous expression of one or more of these markers could identify clinically relevant subgroups of patients with nonseminomatous GCT (NSGCT)...
  20. ncbi request reprint Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma
    Robert J Motzer
    Geritourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 22:454-63. 2004
    ..To describe survival in previously treated patients with metastatic renal cell carcinoma (RCC) who are candidates for clinical trials of new agents as second-line therapy...
  21. pmc Increased shedding of HU177 correlates with worse prognosis in primary melanoma
    Heather K Hamilton
    Department of Dermatology, New York University School of Medicine, New York, NY, USA
    J Transl Med 8:19. 2010
    ..In this study, we investigate the association between HU177 shedding in the sera and clinical outcome in terms of disease-free survival (DFS) and overall survival (OS)...
  22. doi request reprint Predictors of short-term outcomes following endoscopic pituitary surgery
    Abtin Tabaee
    Department of Otolaryngology, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY 10003, USA
    Clin Neurol Neurosurg 111:119-22. 2009
    ..Refinement of endoscopic pituitary surgery requires an understanding of the impact of demographic and surgical variables on outcomes...
  23. pmc Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
    Tomer Mark
    Department of Medicine, Division of Hematology and Medical Oncology, Center of Lymphoma and Myeloma, Weill Medical College of Cornell University, New York Presbyterian Hospital Cornell Medical Center, New York, NY 10021, USA
    Br J Haematol 143:654-60. 2008
    ..This is the first time this phenomenon has been seen with regularity in non-myeloablative therapy for MM. Analogous to the ASCT experience, ASIPs do not signal incipient disease progression, but rather herald robust response...
  24. ncbi request reprint BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma
    Ruben Niesvizky
    Center of Excellence for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital Cornell Medical Center, New York, NY 10021, USA
    Blood 111:1101-9. 2008
    ..BiRD is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed multiple myeloma. This trial was registered at www.clinicaltrials.gov as #NCT00151203...
  25. pmc A high proliferative index of recurrent melanoma is associated with worse survival
    Ting J Tu
    The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY 10016, USA
    Oncology 80:181-7. 2011
    ..We examined the prognostic relevance of recurrent tumor proliferation...
  26. doi request reprint A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981
    Scott T Tagawa
    Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY 10065, USA
    Am J Clin Oncol 34:443-8. 2011
    ..To define the safety [dose limiting toxicity (DLT)] and recommended phase II dose of the combination of sorafenib plus gemcitabine and capecitabine for advanced renal cell carcinoma (RCC)...
  27. pmc Bilateral total knee arthroplasty: risk factors for major morbidity and mortality
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, USA
    Anesth Analg 113:784-90. 2011
    ..Our objective was to determine the incidence and patient-related risk factors for major morbidity and mortality among patients undergoing BTKA...
  28. pmc In-hospital patient falls after total joint arthroplasty: incidence, demographics, and risk factors in the United States
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, New York, New York 10021, USA
    J Arthroplasty 27:823-8.e1. 2012
    ..In-hospital mortality, complications, and cost were higher in patients sustaining IF. Given the associated morbidity, mortality, and increased cost, resources should be allocated to minimize the risk of IF in this population...
  29. pmc Clinical relevance of SKP2 alterations in metastatic melanoma
    Amy E Rose
    Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA
    Pigment Cell Melanoma Res 24:197-206. 2011
    ..Copy number gain is a major contributing mechanism of SKP2 overexpression in metastatic melanoma. Results may have implications for the development of therapeutics that target SKP2...
  30. pmc Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm)
    Melanie A Warycha
    Department of Dermatology, New York University School of Medicine, New York, New York 10016, USA
    Cancer 115:869-79. 2009
    ..The authors performed a meta-analysis to estimate the risk, potential predictors, and outcome of SLN positivity in this group of patients...
  31. ncbi request reprint Phase II trial of bortezomib for patients with advanced renal cell carcinoma
    G Varuni Kondagunta
    Genitourinary Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 22:3720-5. 2004
    ..To assess the efficacy and toxicity of bortezomib (Velcade; Milennium Pharmaceuticals Inc, Cambridge, MA; formerly PS-341) in patients with metastatic renal cell carcinoma (RCC)...
  32. pmc Changes in the presentation of nodular and superficial spreading melanomas over 35 years
    Melanie A Warycha
    Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA
    Cancer 113:3341-8. 2008
    ..To better define the clinical behavior of NMs, the authors compared their clinical and histopathologic features to those of SSMs at their institution, a tertiary referral center, over 3 decades...
  33. ncbi request reprint Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma
    Jeffrey L Port
    Division of Thoracic Surgery, Department of Cardiothoracic Surgery, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA
    Ann Thorac Surg 84:393-400; discussion 400. 2007
    ..This study assessed the predictive accuracy of clinical response (CR) and positron emission tomography (PET) scanning in determining pathological downstaging and disease free survival (DFS) after chemotherapy...
  34. pmc Sleep apnea and total joint arthroplasty under various types of anesthesia: a population-based study of perioperative outcomes
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Reg Anesth Pain Med 38:274-81. 2013
    ..We studied the association of the type of anesthesia and perioperative outcomes in patients with SA undergoing joint arthroplasty...
  35. pmc Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty
    Ottokar Stundner
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Reg Anesth Pain Med 37:638-44. 2012
    ..Therefore, we examined a large sample of BTKA recipients, hypothesizing that neuraxial anesthesia would favorably impact on outcomes...
  36. pmc Factors influencing unexpected disposition after orthopedic ambulatory surgery
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, New York, NY 10021, USA
    J Clin Anesth 24:89-95. 2012
    ..To analyze whether patient characteristics, ambulatory facility type, anesthesia provider and technique, procedure type, and temporal factors impact the outcome of unexpected disposition after ambulatory knee and shoulder surgery...
  37. pmc Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, New York, NY 10021, USA
    Spine (Phila Pa 1976) 37:989-95. 2012
    ..Analysis of the National Inpatient Sample database from 2000 to 2008...
  38. pmc Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma
    Molly Yancovitz
    Department of Dermatology, New York University Langone Medical Center, New York, New York, United States of America
    PLoS ONE 7:e29336. 2012
    ....
  39. ncbi request reprint Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials
    Lawrence H Schwartz
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:1611-9. 2003
    ....
  40. pmc Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34
    Amy E Rose
    Department of Dermatology, New York University School of Medicine, New York, NY, USA
    Am J Surg Pathol 35:1441-9. 2011
    ..27-3.18; P=0.003] and OS (HR, 2.08; 95% CI: 1.25-3.46; P=0.005). Results show that D2-40 and CD34 increase the detection of LVI in primary melanoma and that cases missed by routine histology have prognostic relevance...
  41. pmc Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival
    Jan Zakrzewski
    The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine and New York University Cancer Institute, New York, New York, USA
    Cancer 117:1711-20. 2011
    ..In the current study, the authors attempted to identify primary tumor characteristics and clinical features predictive of B-Met development and post-B-Met survival...
  42. pmc Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma
    Elsa F Velazquez
    Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA
    J Transl Med 5:2. 2007
    ..We investigated the role of NEP expression in the clinical progression of cutaneous melanoma...
  43. ncbi request reprint Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
    Timothy Akhurst
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:8713-6. 2005
    ..Because cytotoxic chemotherapy may decrease the cellular metabolic activity of tumor, we assessed the effects of chemotherapy on PET imaging...
  44. ncbi request reprint Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors
    G Varuni Kondagunta
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Invest New Drugs 22:177-9. 2004
    ..No patient experienced a grade 3 or 4 toxicity, and none of the 14 evaluable patients achieved a complete or partial response. Temozolomide is not efficacious in the treatment of cisplatin-refractory GCT patients...
  45. ncbi request reprint Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma
    Beverly Drucker
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Invest New Drugs 21:341-5. 2003
    ..At the dose and schedule used in this trial, the lack of antitumor activity associated with ZD1839 does not support further study in patients with metastatic RCC...
  46. doi request reprint Inpatient falls after total knee arthroplasty: the role of anesthesia type and peripheral nerve blocks
    Stavros G Memtsoudis
    From the Department of Anesthesiology, Hospital for Special Surgery, New York, New York S G M, T D, and O S Department of Public Health, Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, New York R R, J P, and M M Stony Brook University, Stony Brook, New York P G and Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California E R M
    Anesthesiology 120:551-63. 2014
    ..The aim of the study is to characterize cases of IFs, identify risk factors, and study the role of PNB and anesthesia technique in IF risk in total knee arthroplasty patients...
  47. ncbi request reprint Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma
    Ruben Niesvizky
    Center of Excellence for Lymphoma and Myeloma, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    Leuk Lymphoma 48:2330-7. 2007
    ..Low-dose aspirin appears to reduce the incidence of thrombosis with these regimens. Routine use of aspirin as antithrombotic prophylaxis in MM patients receiving immunomodulatory drugs with corticosteroids is warranted...
  48. doi request reprint Mortality of patients with respiratory insufficiency and adult respiratory distress syndrome after surgery: the obesity paradox
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, New York, NY 10021, USA
    J Intensive Care Med 27:306-11. 2012
    ....
  49. pmc Have bilateral total knee arthroplasties become safer? A population-based trend analysis
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, 535 East 70th Street, New York, NY 10021, USA
    Clin Orthop Relat Res 471:17-25. 2013
    ..It remains unclear whether this development has reduced overall perioperative morbidity and mortality...
  50. ncbi request reprint Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study
    David B Chessin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 12:104-10. 2005
    ..Our purpose was to determine the effect of rectus abdominus myocutaneous (RAM) flap reconstruction on perineal wound morbidity in this population...
  51. ncbi request reprint Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    G Varuni Kondagunta
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 25:85-90. 2007
    ..This prospective trial followed a similarly designed report of TICE, which used a different means of carboplatin dosing...
  52. doi request reprint Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, New York, NY 10021, USA
    Anesth Analg 111:1110-6. 2010
    ..In this study, we evaluated the incidence and risks of perioperative morbidity and mortality in patients with PHTN undergoing primary total hip arthroplasty (THA) and total knee arthroplasty (TKA)...
  53. ncbi request reprint Phase II trial of thalidomide for patients with advanced renal cell carcinoma
    Robert J Motzer
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 20:302-6. 2002
    ..To assess efficacy and toxicity of thalidomide in patients with advanced renal cell carcinoma (RCC)...
  54. pmc Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors
    Elsa F Velazquez
    Ronald O Perelman Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA
    Cancer Immun 7:11. 2007
    ..Our study suggests that patients with metastatic MM who express NY-ESO-1 may benefit from NY-ESO-1-based immunotherapy...
  55. pmc Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes
    Thomas Danninger
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, 535 East 70th Street, New York, NY 10021, USA
    ScientificWorldJournal 2014:623460. 2014
    ..In this study we attempted to determine the proportion of perioperative complications in the orthopedic population attributable to the use of a blood transfusion...
  56. ncbi request reprint Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience
    Robert J Motzer
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Boston, Massachusetts, USA
    Clin Cancer Res 10:6302S-3S. 2004
    ..Investigations into new prognostic factors based on tumor biology are needed and of high priority...
  57. doi request reprint The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States
    Alejandro Gonzalez Della Valle
    Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, USA
    J Arthroplasty 27:1743-1749.e1. 2012
    ..Given the increasing rates of MetS and its association with higher risk for major complications among total joint arthroplasty recipients, further research into the impact of this disease complex is warranted...
  58. pmc Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research
    Yan Ma
    Research Division, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY 10021, USA
    Reg Anesth Pain Med 37:99-105. 2012
    ..The goal of this article was to increase awareness of the advantages of modern statistical methods and promote their use in anesthesia research...
  59. pmc Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment
    Michael Koscuiszka
    Department of Urology, New York University School of Medicine, New York, New York 10016, USA
    Cancer 118:3145-52. 2012
    ....
  60. ncbi request reprint Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases
    Semra Olgac
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Am J Surg Pathol 28:1545-52. 2004
    ..Pathologic stage is the most potent predictor of survival, similar to lower tract disease. A subset of the cases could not be staged due to processing issues; we thus recommend fixation prior to prosecting...
  61. ncbi request reprint Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features
    Satish K Tickoo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Int J Surg Pathol 10:23-32. 2002
    ....
  62. ncbi request reprint Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology
    Robert J Motzer
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:2376-81. 2002
    ..To define outcome data for patients with metastatic renal cell carcinoma (RCC) with histology other than clear-cell type, including collecting duct (or medullary carcinoma), papillary, chromophobe, and unclassified histologies...
  63. ncbi request reprint Methods for categorizing a prognostic variable in a multivariable setting
    Madhu Mazumdar
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 44, New York, NY 10021, U S A
    Stat Med 22:559-71. 2003
    ..An example is provided to illustrate the value of the multivariable cross-validation approach...
  64. pmc Comparative safety of simultaneous and staged anterior and posterior spinal surgery
    Peter G Passias
    Division of Spine Surgery, Department of Orthopaedic Surgery, Hospital for Special Surgery Weill Medical College of Cornell University, New York, NY, USA
    Spine (Phila Pa 1976) 37:247-55. 2012
    ..Analysis of population-based national hospital discharge data collected for the Nationwide Inpatient Sample...
  65. ncbi request reprint Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement
    Lawrence H Schwartz
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 9:4318-23. 2003
    ..This study was performed to systematically evaluate the variability in tumor response assessments that occurs depending on how many tumor deposits are selected for measurement at imaging...
  66. ncbi request reprint Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase in
    Jonathan J Beitler
    Department of Radiation Oncology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York, USA
    Head Neck 29:18-25. 2007
    ..We obtained HU in parenteral form to be administered continually during the radiation treatment. Intravenous HU promised better pharmacokinetics and cell cycle blockade...
  67. ncbi request reprint Some design issues of strata-matched non-randomized studies with survival outcomes
    Madhu Mazumdar
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY 10021, USA
    Stat Med 25:3949-59. 2006
    ..The methodology developed is applied to two illustrative examples in gastric cancer and sarcoma...
  68. ncbi request reprint The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection
    David Bentrem
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10021, USA
    Ann Surg Oncol 12:347-53. 2005
    ....
  69. doi request reprint Factors that impact expectations before total knee arthroplasty
    Matthew S Hepinstall
    Department of Orthopedics, Hospital for Special Surgery, New York, NY 10021, USA
    J Arthroplasty 26:870-6. 2011
    ..Our results suggest that high, possibly unrealistic, expectations of TKA are common and should be moderated to maintain patient satisfaction...
  70. doi request reprint Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
    Gail J Roboz
    Leukemia Program, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York 10021, USA
    Cancer 113:2504-11. 2008
    ..In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low-dose cytarabine in untreated patients aged >or=60 years with AML...
  71. pmc Perioperative outcomes after unilateral and bilateral total knee arthroplasty
    Stavros G Memtsoudis
    Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York, USA
    Anesthesiology 111:1206-16. 2009
    ..The authors sought to study differences in perioperative outcomes between unilateral and BTKA and to further compare BTKAs performed during the same versus different operations during the same hospitalization...
  72. pmc Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
    Abby B Siegel
    Department of Medicine, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032 3784, USA
    J Clin Oncol 26:2992-8. 2008
    ..To determine the clinical and biologic effects of bevacizumab, an anti-vascular endothelial growth factor (VEGF) monoclonal antibody, in unresectable hepatocellular carcinoma (HCC)...
  73. ncbi request reprint A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients
    Harvey G Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 197:22-8. 2003
    ....
  74. doi request reprint Multivariate meta-analysis: a robust approach based on the theory of U-statistic
    Yan Ma
    Research Division, Hospital for Special Surgery, New York, NY 10021, USA
    Stat Med 30:2911-29. 2011
    ..We discuss ideas for future research based on U-statistic for testing significance of between-study heterogeneity and for extending the work to meta-regression setting...
  75. pmc Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience
    Heejung Bang
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, NY, USA
    Nephrol Dial Transplant 24:2452-7. 2009
    ..Recently, CKD screening in individuals with cardiovascular disease (CVD) has been emphasized. We therefore evaluated the SCORED model in CVD patients in order to better understand the implications of CKD screening in this population...
  76. ncbi request reprint Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, C1275 New York, NY 10021, USA
    J Clin Oncol 21:3647-50. 2003
    ..We developed and internally validated a nomogram that combines these factors to predict the probability of 5-year gastric cancer-specific survival on the basis of 1,039 patients treated at a single institution...
  77. ncbi request reprint Tutorial in biostatistics: Analyzing associations between total plasma homocysteine and B vitamins using optimal categorization and segmented regression
    Heejung Bang
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, NY 10021, USA
    Neuroepidemiology 27:188-200. 2006
    ..These methods are often complementary in discovering the underlying complex pattern of association...
  78. ncbi request reprint Salvage chemotherapy for patients with advanced pure seminoma
    Jacqueline Vuky
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 20:297-301. 2002
    ..We describe the response to conventional or high-dose salvage chemotherapy in patients with advanced seminoma who experience disease progression after receiving first-line platinum-based treatment...
  79. ncbi request reprint Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder
    Guido Dalbagni
    Department of Urology, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 20:3193-8. 2002
    ..The aim of this phase I study was to determine the safety and toxicity profile of gemcitabine administered as an intravesical agent in patients with transitional-cell carcinoma (TCC) of the bladder...
  80. ncbi request reprint Group sequential design for comparative diagnostic accuracy studies
    Madhu Mazumdar
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Stat Med 22:727-39. 2003
    ..Boundary determination and sample size calculation are then illustrated through an example from a cancer clinical trial...
  81. ncbi request reprint Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
    Robert J Motzer
    Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 20:289-96. 2002
    ..The data can be applied to design and interpretation of clinical trials of new agents and treatment programs against this refractory malignancy...
  82. ncbi request reprint Prognostic factors for metastatic kidney cancer
    Beverly J Drucker
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Treat Res 116:139-53. 2003
  83. pmc Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy
    Leyo Ruo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 236:75-81. 2002
    ....
  84. ncbi request reprint Total hip and total knee arthroplasties: trends and disparities revisited
    Heejung Bang
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, New York, USA
    Am J Orthop (Belle Mead NJ) 39:E95-102. 2010
    ..Our study also revealed that racial disparities were not confined to the elderly or to low-income populations. This may mean that there is an unmet need for these medical procedures among racial minorities...
  85. ncbi request reprint Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners
    Madhu Mazumdar
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 E 63rd St, 3rd Floor, New York, NY 10021, USA
    Med Decis Making 24:525-33. 2004
    ..The purpose of this article is to introduce the group sequential design (GSD) approach in planning these larger trials...
  86. doi request reprint Improved reporting of statistical design and analysis: guidelines, education, and editorial policies
    Madhu Mazumdar
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY, USA
    Methods Mol Biol 620:563-98. 2010
    ..In this chapter, we provide an overview of these issues with emphasis to the field of molecular biology and highlight the need for continuing efforts on all fronts...
  87. ncbi request reprint A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response
    Madhu Mazumdar
    Division of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, 411 E 69th St, KB 323, New York, NY 10021, USA
    J Clin Epidemiol 58:150-3. 2005
    ....
  88. ncbi request reprint Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma
    Molly Yancovitz
    Department of Dermatology, New York University School of Medicine, New York, NY 10016, USA
    Cancer 110:1107-14. 2007
    ..In patients with T1b-T3b cutaneous melanoma the utility of radiologic imaging at the time of diagnosis is unclear. Whether initial imaging led to a change in stage or treatment plan was investigated...
  89. ncbi request reprint Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma
    Yao Tseng Chen
    Department of Pathology and Laboratory Medicine, Weill Medical College, Cornell University, New York, NY 10021, USA
    Clin Cancer Res 11:6558-66. 2005
    ..Whether these renal tumors can be distinguished by their mRNA expression profile of a few selected genes was examined...
  90. ncbi request reprint Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse
    Hsuan Ying Huang
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:548-58. 2005
    ..We provide the first combined prognostic analysis of these three molecular parameters in ES...
  91. ncbi request reprint Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy
    Ruben Niesvizky
    Center of Excellence for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York Presbytarian Hospital Cornell Medical Center, New York, NY 10021, USA
    Br J Haematol 138:640-3. 2007
    ..Caution should be exercised when lenalidomide therapy is commenced and CrCl should be incorporated as a determinant of the initial dosing of lenalidomide in MM patients...
  92. ncbi request reprint Role of CT in the management of recurrent ovarian cancer
    Stacey A Funt
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 182:393-8. 2004
    ..The purpose of this study was to evaluate the potential role of preoperative CT in patients with recurrent ovarian cancer who undergo secondary cytoreductive surgery...
  93. pmc NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer
    Duncan Hughes
    Department of General Surgery, Weill Cornell Medical College, New York, NY 10065, USA
    Cancer Prev Res (Phila) 1:241-9. 2008
    ..Collectively, these data indicate that 15-PGDH is commonly down-regulated in NSCLC, an effect that contributes to the accumulation of multiple bioactive lipids in NSCLC...
  94. pmc DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia
    Maria E Figueroa
    Department of Medicine, Hematology Oncology Division, Weill Cornell Medical College, New York, NY 10065, USA
    Cancer Cell 17:13-27. 2010
    ..We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p < 0.001, adjusted for known covariates)...
  95. doi request reprint Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
    Stefan Worgall
    Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA
    Hum Gene Ther 19:463-74. 2008
    ..On this basis, we propose that additional studies to assess the safety and efficacy of AAV-mediated gene therapy for LINCL are warranted...
  96. ncbi request reprint Power and sample size calculation of comparative diagnostic accuracy studies with multiple correlated test results
    Aiyi Liu
    Division of Epidemiology, Statistics and Prevention Research, National Institute of Child Health and Human Development, Department of Health and Human Services, 6100 Executive Blvd, Rockville, MD 20852, USA
    Biom J 47:140-50. 2005
    ..We derive test statistics and obtain power and sample size formulas. The methods are illustrated using an example of comparison of CT and PET scanner for detecting extra-hepatic disease for colorectal cancer...
  97. doi request reprint Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED
    Heejung Bang
    Arch Intern Med 168:432-5. 2008
  98. pmc A letter to the editor in reply to "susceptibility to guillain-barre syndrome is associated to polymorphisms of CD1 genes" by Caporale et al. in the J of Neuroimmunology (2006), 177:112-118
    Heejung Bang
    J Neuroimmunol 186:201-2. 2007
  99. ncbi request reprint Measuring hepatic metastases to colon cancer
    Lawrence H Schwartz
    AJR Am J Roentgenol 187:W552; author reply W553. 2006
  100. ncbi request reprint Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
    Jean Pierre Pignon
    Unit of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
    Anticancer Drugs 15:331-40. 2004
    ..We conclude that this improved survival might be due either to docetaxel's pharmacologic effect or to uncontrolled prognostic factors...